Tags
Language
Tags
July 2025
Su Mo Tu We Th Fr Sa
29 30 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31 1 2
    Attention❗ To save your time, in order to download anything on this site, you must be registered 👉 HERE. If you do not have a registration yet, it is better to do it right away. ✌

    ( • )( • ) ( ͡⚆ ͜ʖ ͡⚆ ) (‿ˠ‿)
    SpicyMags.xyz

    2022 Nelson's Pediatric Antimicrobial Therapy, 28th Edition

    Posted By: yoyoloit
    2022 Nelson's Pediatric Antimicrobial Therapy, 28th Edition

    2022 Nelson's Pediatric Antimicrobial Therapy
    by Bradley, John S.;Nelson, John D.;Elizabeth, Barnett;Cantey, Joseph B.;Kimberlin, David W.;Palumbo, Paul E.;Sauberan, Jason;Smart, J. Howard;Steinbach, William J.;

    English | 2022 | ISBN: ‎ 1610025644, 978-1610025645 | 382 pages | True PDF | 3.55 MB

    Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children.

    For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.

    TOPICS INCLUDE

    Antimicrobial Therapy by Clinical Syndromes
    Antimicrobial Therapy for Neonates
    Choosing Among
    Antibiotics
    Antifungal Agents
    Antiviral Agents
    Antiparasitic Agents
    Oral Step-down Therapy for Serious Infections
    Prevention of Symptomatic Infection
    Approach to Antibiotic Allergies
    Antibiotic Stewardship
    New in the 28th Edition
    Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections
    Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021–2022
    Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase–producing enteric bacilli, if susceptible
    Cefiderocol, a new iron-binding siderophore cephalosporin class, recently approved in adults for treatment of many drug-resistant pathogens, particularly Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in children
    New dosing for posaconazole suspension formulation
    New approaches to mucormycosis
    Added baloxavir for children 12+ years old